ANTX Competitors & Alternatives
Compare AN2 Therapeutics Inc with similar stocks in the same industry
Biotechnology
ANTX
Main Stock$4.42
Tradestie Score
53
Market Cap
$35.25M
Analyst Upside
+103.6%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$14.98
|
$211.22M | - | 54 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.56
|
$202.58M | - | 56 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$27.74
|
$188.81M | 333.6 | 54 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.84
|
$170.45M | - | 55 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.40
|
$158.43M | - | 60 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.57
|
$154.27M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.90
|
$133.50M | - | 57 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.05
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
ABOS
Acumen Pharmaceuticals, Inc. Common Stock
|
$2.74
|
$106.00M | - | 60 | Compare |
More ANTX Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry